ci 988 has been researched along with tetrodotoxin in 6 studies
Studies (ci 988) | Trials (ci 988) | Recent Studies (post-2010) (ci 988) | Studies (tetrodotoxin) | Trials (tetrodotoxin) | Recent Studies (post-2010) (tetrodotoxin) |
---|---|---|---|---|---|
147 | 8 | 14 | 12,992 | 11 | 1,477 |
Protein | Taxonomy | ci 988 (IC50) | tetrodotoxin (IC50) |
---|---|---|---|
Sodium channel protein type 9 subunit alpha | Homo sapiens (human) | 0.0186 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (83.33) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Corwin, RL; Crawley, JN; Hardy, M; Jörn, A | 1 |
Black, JW; Shankley, NP; Welsh, NJ | 1 |
Rakovska, A | 1 |
Champagnat, J; Denavit-Saubie, M; McLean, HA | 1 |
Durieux, C; Léna, I; Roques, BP | 1 |
Antonelli, T; Bebe, BW; Ferraro, L; Glennon, J; O'Connor, WT; Tanganelli, S; Tomasini, MC | 1 |
6 other study(ies) available for ci 988 and tetrodotoxin
Article | Year |
---|---|
The CCK-B antagonist CI-988 increases dopamine levels in microdialysate from the rat nucleus accumbens via a tetrodotoxin- and calcium-independent mechanism.
Topics: Animals; Calcium; Cholecystokinin; Dopamine; Dopamine Antagonists; Indoles; Male; Meglumine; Microdialysis; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Tetrodotoxin | 1995 |
Comparative analysis of the vagal stimulation of gastric acid secretion in rodent isolated stomach preparations.
Topics: Animals; Atropine; Cholecystokinin; Cholinergic Antagonists; Electric Stimulation; Gastric Acid; Gastric Mucosa; Guinea Pigs; Hexamethonium Compounds; Histamine H2 Antagonists; Hydrogen-Ion Concentration; In Vitro Techniques; Indoles; Male; Meglumine; Mice; Rats; Rats, Wistar; Receptors, Cholecystokinin; Species Specificity; Tetrodotoxin; Vagus Nerve | 1994 |
Cholecystokinin-GABA interactions in rat striatum.
Topics: Animals; Calcium; Cholecystokinin; Corpus Striatum; Electric Stimulation; gamma-Aminobutyric Acid; Hormone Antagonists; Indoles; Male; Meglumine; Proglumide; Rats; Rats, Wistar; Receptors, Cholecystokinin; Sincalide; Tetrodotoxin; Tritium | 1995 |
A cholecystokinin-B receptor antagonist potentiates GABAergic and glycinergic inhibition in the nucleus of the solitary tract of the rat.
Topics: Animals; Anti-Anxiety Agents; Chloride Channel Agonists; Drug Synergism; Electric Conductivity; Evoked Potentials; gamma-Aminobutyric Acid; Glycine; Hormone Antagonists; In Vitro Techniques; Indoles; Male; Meglumine; Neural Inhibition; Rats; Rats, Wistar; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Solitary Nucleus; Tetrodotoxin | 1996 |
Dual modulation of dopamine release from anterior nucleus accumbens through cholecystokinin-B receptor subsites.
Topics: Animals; Benzodiazepinones; Binding Sites; Calcium; Cholecystokinin; Culture Media; Devazepide; Dopamine; Hormone Antagonists; Indoles; Male; Meglumine; Nucleus Accumbens; Peptide Fragments; Potassium; Rats; Rats, Wistar; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Tetrodotoxin | 1997 |
Evidence for a nucleus accumbens CCK2 receptor regulation of rat ventral pallidal GABA levels: a dual probe microdialysis study.
Topics: Animals; Bicuculline; Devazepide; gamma-Aminobutyric Acid; Hormone Antagonists; Indoles; Male; Meglumine; Microdialysis; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Receptors, Cholecystokinin; Sincalide; Tetrodotoxin | 2000 |